Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Swallowing behaviours and feeding environment in relation to communication development from early infancy to 6 years of age: a scoping review protocol.

Flowers H, Bérubé D, Ebrahimipour M, Perrier MF, Moloci S, Skoretz S.

BMJ Open. 2019 Aug 18;9(8):e028850. doi: 10.1136/bmjopen-2018-028850.

2.

Exploring Stereotypes of Athletes With a Disability: A Behaviors From Intergroup Affect and Stereotypes Map Comparison.

Stone RC, Sweet SN, Perrier MJ, MacDonald T, Martin Ginis KA, Latimer-Cheung AE.

Adapt Phys Activ Q. 2019 Jun 27;36(3):339-358. doi: 10.1123/apaq.2018-0066.

PMID:
31155920
3.

Correlation between muscle mass and handgrip strength in digestive cancer patients undergoing chemotherapy.

Moreau J, Ordan MA, Barbe C, Mazza C, Perrier M, Botsen D, Brasseur M, Portefaix C, Renard Y, Tallière B, Bertin E, Hoeffel C, Bouché O.

Cancer Med. 2019 Jul;8(8):3677-3684. doi: 10.1002/cam4.2238. Epub 2019 May 21.

4.

New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations.

Castain L, Perrier M, Charpentier C, Palich R, Desire N, Wirden M, Descamps D, Sayon S, Landman R, Valantin MA, Joly V, Peytavin G, Yazdanpanah Y, Katlama C, Calvez V, Marcelin AG, Todesco E.

J Antimicrob Chemother. 2019 Jul 1;74(7):2019-2023. doi: 10.1093/jac/dkz151.

PMID:
31050739
5.

Anterior ischemic stroke: Comparison of two clinical outcome prediction scores through the investigation of cerebral collaterals using multiphase CT angiography.

Nigron A, Bourgois N, Dao S, Lambert C, Perrier M, Akono S, Moreno R, Chabert E, Jean B, Claise B, Gerbaud L, Boyer L, Zerroug A.

J Neuroradiol. 2019 Apr 12. pii: S0150-9861(18)30388-2. doi: 10.1016/j.neurad.2019.03.016. [Epub ahead of print]

PMID:
30986430
6.

Assessment of fed-batch cultivation strategies for an inducible CHO cell line.

Mellahi K, Brochu D, Gilbert M, Perrier M, Ansorge S, Durocher Y, Henry O.

J Biotechnol. 2019 Jun 10;298:45-56. doi: 10.1016/j.jbiotec.2019.04.005. Epub 2019 Apr 5.

PMID:
30959136
7.

Surgical Site Infection in Endometriosis Surgery Is a Rare Complication: Results of a Single Center's Prospective Surveillance of Eight Hundred Ninety-Six Procedures.

Balayé P, Josset V, Mias S, Perrier MA, Lebaron C, Roman H, Merle V.

Surg Infect (Larchmt). 2019 Jul;20(5):395-398. doi: 10.1089/sur.2018.209. Epub 2019 Feb 28.

PMID:
30817227
8.

HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen.

Perrier M, Castain L, Regad L, Todesco E, Landman R, Visseaux B, Yazdanpanah Y, Rodriguez C, Joly V, Calvez V, Marcelin AG, Descamps D, Charpentier C.

J Antimicrob Chemother. 2019 Jun 1;74(6):1679-1692. doi: 10.1093/jac/dkz043.

PMID:
30768160
9.

Process intensification for the production of rituximab by an inducible CHO cell line.

Mellahi K, Brochu D, Gilbert M, Perrier M, Ansorge S, Durocher Y, Henry O.

Bioprocess Biosyst Eng. 2019 May;42(5):711-725. doi: 10.1007/s00449-019-02075-z. Epub 2019 Jan 23.

PMID:
30673843
10.

Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification.

Désiré N, Cerutti L, Le Hingrat Q, Perrier M, Emler S, Calvez V, Descamps D, Marcelin AG, Hué S, Visseaux B.

Retrovirology. 2018 Dec 22;15(1):80. doi: 10.1186/s12977-018-0461-y.

11.

Process development for an inducible rituximab-expressing Chinese hamster ovary cell line.

Mellahi K, Cambay F, Brochu D, Gilbert M, Perrier M, Ansorge S, Durocher Y, Henry O.

Biotechnol Prog. 2019 Jan;35(1):e2742. doi: 10.1002/btpr.2742. Epub 2018 Nov 30.

PMID:
30414355
12.

Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients.

Botsen D, Ordan MA, Barbe C, Mazza C, Perrier M, Moreau J, Brasseur M, Renard Y, Taillière B, Slimano F, Bertin E, Bouché O.

BMC Cancer. 2018 Oct 4;18(1):955. doi: 10.1186/s12885-018-4860-1.

13.

Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants.

Perrier M, Désiré N, Storto A, Todesco E, Rodriguez C, Bertine M, Le Hingrat Q, Visseaux B, Calvez V, Descamps D, Marcelin AG, Charpentier C.

PLoS One. 2018 Jun 1;13(6):e0198334. doi: 10.1371/journal.pone.0198334. eCollection 2018.

14.

Presence of Human Papillomavirus (HPV) Apolipoprotein B Messenger RNA Editing, Catalytic Polypeptide-Like 3 (APOBEC)-Related Minority Variants in HPV-16 Genomes From Anal and Cervical Samples but Not in HPV-52 and HPV-58.

Mariaggi AA, Péré H, Perrier M, Visseaux B, Collin G, Veyer D, Le Hingrat Q, Ferré VM, Joly V, Couvelard A, Bucau M, Davitian C, Descamps D, Abramowitz L, Charpentier C.

J Infect Dis. 2018 Aug 24;218(7):1027-1036. doi: 10.1093/infdis/jiy287.

PMID:
29788374
15.

Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads.

Le Hingrat Q, Perrier M, Collin G, Drumard S, Storto A, Bertine M, Larrouy L, Matheron S, Damond F, Charpentier C, Descamps D, Visseaux B.

J Virol Methods. 2018 Jul;257:12-15. doi: 10.1016/j.jviromet.2018.03.010. Epub 2018 Mar 26.

PMID:
29588254
16.

High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort.

Charpentier C, Peytavin G, Lê MP, Joly V, Cabras O, Perrier M, Le Gac S, Phung B, Yazdanpanah Y, Descamps D, Landman R.

J Antimicrob Chemother. 2018 Jun 1;73(6):1665-1671. doi: 10.1093/jac/dky062.

PMID:
29528412
17.

Real-time monitoring of a microbial electrolysis cell using an electrical equivalent circuit model.

Hussain SA, Perrier M, Tartakovsky B.

Bioprocess Biosyst Eng. 2018 Apr;41(4):543-553. doi: 10.1007/s00449-017-1889-5. Epub 2018 Feb 2.

PMID:
29396708
18.

Feasibility of systematic handgrip strength testing in digestive cancer patients treated with chemotherapy: The FIGHTDIGO study.

Ordan MA, Mazza C, Barbe C, Perrier M, Botsen D, Renard Y, Moreau J, Brasseur M, Taillière B, Bertin É, Bouché O.

Cancer. 2018 Apr 1;124(7):1501-1506. doi: 10.1002/cncr.31207. Epub 2017 Dec 26.

19.

Two-Particle Four-Mode Interferometer for Atoms.

Dussarrat P, Perrier M, Imanaliev A, Lopes R, Aspect A, Cheneau M, Boiron D, Westbrook CI.

Phys Rev Lett. 2017 Oct 27;119(17):173202. doi: 10.1103/PhysRevLett.119.173202. Epub 2017 Oct 24.

PMID:
29219424
20.

HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study.

Charpentier C, Montes B, Perrier M, Meftah N, Reynes J.

J Antimicrob Chemother. 2017 Oct 1;72(10):2831-2836. doi: 10.1093/jac/dkx233.

PMID:
29091218
21.

Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients.

Perrier M, Bertine M, Le Hingrat Q, Joly V, Visseaux B, Collin G, Landman R, Yazdanpanah Y, Descamps D, Charpentier C.

J Antimicrob Chemother. 2017 Oct 1;72(10):2954-2955. doi: 10.1093/jac/dkx208. No abstract available.

PMID:
29091184
22.

No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir.

Perrier M, Visseaux B, Landman R, Joly V, Todesco E, Yazdanpanah Y, Calvez V, Marcelin AG, Descamps D, Charpentier C.

J Antimicrob Chemother. 2018 Jan 1;73(1):173-176. doi: 10.1093/jac/dkx366.

PMID:
29077926
23.

Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort.

Perrier M, Charpentier C, Peytavin G, Lê M, Blondel L, Visseaux B, Joly V, Pinto A, Matheron S, Yazdanpanah Y, Descamps D, Landman R.

J Antimicrob Chemother. 2017 Jun 1;72(6):1745-1751. doi: 10.1093/jac/dkx018.

PMID:
28186251
24.

Changing health-promoting behaviours through narrative interventions: A systematic review.

Perrier MJ, Martin Ginis KA.

J Health Psychol. 2018 Sep;23(11):1499-1517. doi: 10.1177/1359105316656243. Epub 2016 Jul 7.

PMID:
27387514
25.

Type, intensity and duration of daily physical activities performed by adults with spinal cord injury.

Perrier MJ, Stork MJ, Martin Ginis KA; SHAPE-SCI Research Group.

Spinal Cord. 2017 Jan;55(1):64-70. doi: 10.1038/sc.2016.86. Epub 2016 Jun 7.

PMID:
27271116
26.

Limitations in ionization-induced compression of femtosecond laser pulses due to spatio-temporal couplings.

Beaurepaire B, Guénot D, Vernier A, Böhle F, Perrier M, Jullien A, Lopez-Martens R, Lifschitz A, Faure J.

Opt Express. 2016 May 2;24(9):9693-705. doi: 10.1364/OE.24.009693.

PMID:
27137583
27.

Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals.

Perrier M, Désiré N, Deback C, Agut H, Boutolleau D, Burrel S.

J Virol Methods. 2016 Jul;233:10-4. doi: 10.1016/j.jviromet.2016.03.006. Epub 2016 Mar 16.

PMID:
26994966
28.

A description and estimate of very low-intensity activity and inactive awake time in community-dwelling adults with chronic spinal cord injury.

Perrier MJ, Martin Ginis KA.

Spinal Cord. 2016 Sep;54(9):709-13. doi: 10.1038/sc.2015.232. Epub 2016 Jan 19.

PMID:
26782843
29.

Combined bioelectrochemical-electrical model of a microbial fuel cell.

Recio-Garrido D, Perrier M, Tartakovsky B.

Bioprocess Biosyst Eng. 2016 Feb;39(2):267-76. doi: 10.1007/s00449-015-1510-8. Epub 2015 Dec 16.

PMID:
26677137
30.

Active Living Leaders Training Program for adults with spinal cord injury: a pilot study.

Salci LE, Perrier MJ, Ginis S, Martin Ginis KA.

Spinal Cord. 2016 Sep;54(9):662-9. doi: 10.1038/sc.2015.168. Epub 2015 Oct 20.

PMID:
26481706
31.

Narrative interventions for health screening behaviours: A systematic review.

Perrier MJ, Martin Ginis KA.

J Health Psychol. 2017 Mar;22(3):375-393. doi: 10.1177/1359105315603463. Epub 2016 Jul 10. Review.

PMID:
26359288
32.

Psychosocial factors associated with physical activity in ambulatory and manual wheelchair users with spinal cord injury: a mixed-methods study.

Martin Ginis KA, Papathomas A, Perrier MJ, Smith B; SHAPE-SCI Research Group.

Disabil Rehabil. 2017 Jan;39(2):187-192. Epub 2015 Jun 24.

PMID:
26104107
33.

Investigation of cyano-bridged coordination nanoparticles Gd(3+)/[Fe(CN)6](3-)/D-mannitol as T1-weighted MRI contrast agents.

Perrier M, Gallud A, Ayadi A, Kennouche S, Porredon C, Gary-Bobo M, Larionova J, Goze-Bac Ch, Zanca M, Garcia M, Basile I, Long J, de Lapuente J, Borras M, Guari Y.

Nanoscale. 2015 Jul 28;7(28):11899-903. doi: 10.1039/c5nr01557j. Epub 2015 May 13.

PMID:
25967733
34.

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.

Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S.

Clin Infect Dis. 2015 Aug 15;61(4):593-600. doi: 10.1093/cid/civ333. Epub 2015 Apr 22.

PMID:
25904368
35.

Lack of dissemination of acquired resistance to β-lactams in small wild mammals around an isolated village in the Amazonian forest.

Grall N, Barraud O, Wieder I, Hua A, Perrier M, Babosan A, Gaschet M, Clermont O, Denamur E, Catzeflis F, Decré D, Ploy MC, Andremont A.

Environ Microbiol Rep. 2015 Oct;7(5):698-708. doi: 10.1111/1758-2229.12289. Epub 2015 Jun 10.

PMID:
25858231
36.

Sport participation among individuals with acquired physical disabilities: group differences on demographic, disability, and Health Action Process Approach constructs.

Perrier MJ, Shirazipour CH, Latimer-Cheung AE.

Disabil Health J. 2015 Apr;8(2):216-22. doi: 10.1016/j.dhjo.2014.09.009. Epub 2014 Oct 12.

PMID:
25458978
37.

²⁰¹Tl⁺-labelled Prussian blue nanoparticles as contrast agents for SPECT scintigraphy.

Perrier M, Busson M, Massasso G, Long J, Boudousq V, Pouget JP, Peyrottes S, Perigaud Ch, Porredon-Guarch C, de Lapuente J, Borras M, Larionova J, Guari Y.

Nanoscale. 2014 Nov 21;6(22):13425-9. doi: 10.1039/c4nr03044c.

PMID:
25283238
38.

In vivo quantitative NMR imaging of fruit tissues during growth using Spoiled Gradient Echo sequence.

Kenouche S, Perrier M, Bertin N, Larionova J, Ayadi A, Zanca M, Long J, Bezzi N, Stein PC, Guari Y, Cieslak M, Godin C, Goze-Bac C.

Magn Reson Imaging. 2014 Dec;32(10):1418-27. doi: 10.1016/j.mri.2014.08.005. Epub 2014 Aug 15.

PMID:
25131625
39.

Narratives of athletic identity after acquiring a permanent physical disability.

Perrier MJ, Smith B, Strachan SM, Latimer AE.

Adapt Phys Activ Q. 2014 Apr;31(2):106-24. doi: 10.1123/apaq.2012-0076.

PMID:
24762386
40.

Investigation on NMR relaxivity of nano-sized cyano-bridged coordination polymers.

Perrier M, Kenouche S, Long J, Thangavel K, Larionova J, Goze-Bac C, Lascialfari A, Mariani M, Baril N, Guérin C, Donnadieu B, Trifonov A, Guari Y.

Inorg Chem. 2013 Dec 2;52(23):13402-14. doi: 10.1021/ic401710j. Epub 2013 Nov 18.

PMID:
24245933
41.

Pulse-width modulated external resistance increases the microbial fuel cell power output.

Coronado J, Perrier M, Tartakovsky B.

Bioresour Technol. 2013 Nov;147:65-70. doi: 10.1016/j.biortech.2013.08.005. Epub 2013 Aug 9.

PMID:
23989037
42.

Narrative environments and the capacity of disability narratives to motivate leisure-time physical activity among individuals with spinal cord injury.

Perrier MJ, Smith BM, Latimer-Cheung AE.

Disabil Rehabil. 2013;35(24):2089-96. doi: 10.3109/09638288.2013.821179. Epub 2013 Aug 6.

PMID:
23919641
43.

Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women.

Ruppé E, Lixandru B, Cojocaru R, Büke C, Paramythiotou E, Angebault C, Visseaux C, Djuikoue I, Erdem E, Burduniuc O, El Mniai A, Marcel C, Perrier M, Kesteman T, Clermont O, Denamur E, Armand-Lefèvre L, Andremont A.

Antimicrob Agents Chemother. 2013 Sep;57(9):4512-7. doi: 10.1128/AAC.00238-13. Epub 2013 Jul 8.

44.

Identifying physical activity information needs and preferred methods of delivery of people with multiple sclerosis.

Sweet SN, Perrier MJ, Podzyhun C, Latimer-Cheung AE.

Disabil Rehabil. 2013;35(24):2056-63. doi: 10.3109/09638288.2013.800915. Epub 2013 Jun 13.

PMID:
23763468
45.

Enhanced cooperative interactions at the nanoscale in spin-crossover materials with a first-order phase transition.

Félix G, Nicolazzi W, Salmon L, Molnár G, Perrier M, Maurin G, Larionova J, Long J, Guari Y, Bousseksou A.

Phys Rev Lett. 2013 Jun 7;110(23):235701. Epub 2013 Jun 4.

PMID:
25167512
46.

Evidence-informed recommendations for constructing and disseminating messages supplementing the new Canadian Physical Activity Guidelines.

Latimer-Cheung AE, Rhodes RE, Kho ME, Tomasone JR, Gainforth HL, Kowalski K, Nasuti G, Perrier MJ, Duggan M; Canadian Physical Activity Guidelines Messaging Recommendation Workgroup.

BMC Public Health. 2013 May 1;13:419. doi: 10.1186/1471-2458-13-419.

47.

Long-term functional benefits of epicardial patches as cell carriers.

Hamdi H, Planat-Benard V, Bel A, Neamatalla H, Saccenti L, Calderon D, Bellamy V, Bon M, Perrier MC, Mandet C, Bruneval P, Casteilla L, Hagège AA, Pucéat M, Agbulut O, Menasché P.

Cell Transplant. 2014 Jan;23(1):87-96. doi: 10.3727/096368912X658836. Epub 2012 Nov 1.

PMID:
23127387
48.

Peculiar field-dependent magnetic behavior of cyano-bridged coordination polymer Er(H2O)4[W(CN)8].

Perrier M, Long J, Paz FA, Guari Y, Larionova J.

Inorg Chem. 2012 Jun 18;51(12):6425-7. doi: 10.1021/ic2024988. Epub 2012 May 31.

PMID:
22651574
49.

An investigation of seasonal variation in leisure-time physical activity in persons with spinal cord injury.

Perrier MJ, Latimer-Cheung AE, Ginis KA; SHAPE-SCI Research Team.

Spinal Cord. 2012 Jul;50(7):507-11. doi: 10.1038/sc.2012.11. Epub 2012 Mar 6.

PMID:
22391685
50.

Factors that influence physical activity in long-term care: perspectives of residents, staff, and significant others.

Benjamin K, Edwards N, Guitard P, Murray MA, Caswell W, Perrier MJ.

Can J Aging. 2011 Jun;30(2):247-58. doi: 10.1017/S0714980811000080.

PMID:
24650673

Supplemental Content

Loading ...
Support Center